Literature DB >> 35080706

Testing Precision Limits of Neural Network-Based Quality Control Metrics in High-Throughput Digital Microscopy.

Christopher P Calderon1,2, Dean C Ripple3, Charudharshini Srinivasan4, Youlong Ma4, Michael J Carrier3, Theodore W Randolph5, Thomas F O'Connor4.   

Abstract

OBJECTIVE: Digital microscopy is used to monitor particulates such as protein aggregates within biopharmaceutical products. The images that result encode a wealth of information that is underutilized in pharmaceutical process monitoring. For example, images of particles in protein drug products typically are analyzed only to obtain particle counts and size distributions, even though the images also reflect particle characteristics such as shape and refractive index. Multiple groups have demonstrated that convolutional neural networks (CNNs) can extract information from images of protein aggregates allowing assignment of the likely stress at the "root-cause" of aggregation. A practical limitation of previous CNN-based approaches is that the potential aggregation-inducing stresses must be known a priori, disallowing identification of particles produced by unknown stresses.
METHODS: We demonstrate an expanded CNN analysis of flow imaging microscopy (FIM) images incorporating judiciously chosen particle standards within a recently proposed "fingerprinting algorithm" (Biotechnol. & Bioeng. (2020) 117:3322) that allows detection of particles formed by unknown root-causes. We focus on ethylene tetrafluoroethylene (ETFE) microparticles as standard surrogates for protein aggregates. We quantify the sensitivity of the new algorithm to experimental parameters such as microscope focus and solution refractive index changes, and explore how FIM sample noise affects statistical testing procedures. RESULTS &
CONCLUSIONS: Applied to real-world microscopy images of protein aggregates, the algorithm reproducibly detects complex, distinguishing "textural features" of particles that are not easily described by standard morphological measurements. This offers promise for quality control applications and for detecting shifts in protein aggregate populations due to stresses resulting from unknown process upsets.
© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Entities:  

Keywords:  Artificial intelligence analysis; Convolutional Neural Networks (CNNs); Digital microscopy; Flow Imaging Microscopy (FIM); Protein surrogates; Protein therapeutics; Quality control; Statistical diagnostics

Mesh:

Substances:

Year:  2022        PMID: 35080706     DOI: 10.1007/s11095-021-03130-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  2 in total

1.  Discrimination between silicone oil droplets and protein aggregates in biopharmaceuticals: a novel multiparametric image filter for sub-visible particles in microflow imaging analysis.

Authors:  René Strehl; Verena Rombach-Riegraf; Manuel Diez; Kamal Egodage; Markus Bluemel; Margit Jeschke; Atanas V Koulov
Journal:  Pharm Res       Date:  2011-09-27       Impact factor: 4.200

2.  Subvisible Particle Content, Formulation, and Dose of an Erythropoietin Peptide Mimetic Product Are Associated With Severe Adverse Postmarketing Events.

Authors:  Joseph Kotarek; Christine Stuart; Silvia H De Paoli; Jan Simak; Tsai-Lien Lin; Yamei Gao; Mikhail Ovanesov; Yideng Liang; Dorothy Scott; Janice Brown; Yun Bai; Dean D Metcalfe; Ewa Marszal; Jack A Ragheb
Journal:  J Pharm Sci       Date:  2016-02-03       Impact factor: 3.534

  2 in total
  2 in total

1.  Machine Learning Analysis Provides Insight into Mechanisms of Protein Particle Formation Inside Containers During Mechanical Agitation.

Authors:  Nidhi G Thite; Saba Ghazvini; Nicole Wallace; Naomi Feldman; Christopher P Calderon; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2022-07-11       Impact factor: 3.784

2.  Combining Machine Learning and Backgrounded Membrane Imaging: A Case Study in Comparing and Classifying Different Types of Biopharmaceutically Relevant Particles.

Authors:  Christopher P Calderon; Ana Krhač Levačić; Constanze Helbig; Klaus Wuchner; Tim Menzen
Journal:  J Pharm Sci       Date:  2022-06-01       Impact factor: 3.784

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.